DUBLIN--(BUSINESS WIRE)--The "Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2017-2021" report has been added to Research and Markets' offering.
The global hematopoietic stem cells transplantation (HSCT) market is forecast to grow at a CAGR of 5.75% during the period 2017-2021.
The report, Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of theKey vendors operating in this market.
The latest trend gaining momentum in the market is the growing demand for personalized medicine. Personalized medicine can offer treatments based on the patient's characteristics, needs, and preferences. Therefore, research organizations are extensively exploring ways to develop personalized treatments by using mesenchymal stem cells owing to its higher benefits. Their benefits include low risk of immune rejection, no requirement of embryonic stem cell, limited need for anti-rejection drugs, low risk of graft rejection, and less chance of developing GvHD.
According to the report, one of the major drivers for this market is the rising number of HSCT. Owing to the efficacy of HSCT, their demand is ever growing for treating leukemia, lymphoma, immune-deficiency illnesses, hemoglobinopathies, congenital metabolic defects, and myelodysplastic and myeloproliferative syndromes. Further, over the period of time, it has been observed that the allogenic HSCT outweighs the autologous transplants despite allogenic being more susceptible to GvHD.
Key vendors
- AllCells
- Lonza
- Merck
- Sanofi
Other prominent vendors
- Athersys
- Beike Biotechnology
- BioTime
- bluebird bio
- Caladrius
- Cellular Biomedicine Group
-
Others
Key Topics Covered:
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Research Methodology
Part 04: Introduction
Part 05: Hsct: An Overview
Part 06: Pipeline
Part 07: Market Landscape
Part 08: Market Segmentation By Therapeutic Application
Part 09: Market Segmentation By Transplant
Part 10: Geographical Segmentation
Part 11: Decision Framework
Part 12: Drivers And Challenges
Part 13: Market Trends
Part 14: Vendor Landscape
Part 15: Key Vendor Analysis
Part 16: Appendix
For more information about this report visit https://www.researchandmarkets.com/research/m4cg8n/global
